Carlo Caltagirone
Overview
Explore the profile of Carlo Caltagirone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
682
Citations
15191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Assogna M, Di Lorenzo F, Bonni S, Borghi I, Cerulli Irelli E, Mencarelli L, et al.
Brain Commun
. 2025 Mar;
7(2):fcaf080.
PMID: 40046339
Frontotemporal dementia is a devastating neurodegenerative disorder for which no pharmacological treatments have been approved. Neuroinflammation plays a central role in driving the pathogenic mechanisms underlying frontotemporal dementia. In the...
2.
Fabrizio C, Termine A, Caltagirone C
J Cent Nerv Syst Dis
. 2025 Feb;
17:11795735241286821.
PMID: 39906346
Background: Parkinson's Disease (PD) varies widely among individuals, and Artificial Intelligence (AI) has recently helped to identify three disease progression subtypes. While their clinical features are already known, their gene...
3.
Zampatti S, Farro J, Peconi C, Cascella R, Strafella C, Calvino G, et al.
Genes (Basel)
. 2025 Jan;
16(1).
PMID: 39858576
Background/objectives: Artificial intelligence and large language models like ChatGPT and Google's Gemini are promising tools with remarkable potential to assist healthcare professionals. This study explores ChatGPT and Gemini's potential utility...
4.
Trastulli G, Calvino G, Papasergi B, Megalizzi D, Peconi C, Zampatti S, et al.
Diagnostics (Basel)
. 2025 Jan;
15(2).
PMID: 39857032
: Centralizing genetic sequencing in specialized facilities is pivotal for reducing the costs associated with diagnostic testing. These centers must be able to verify data quality and ensure sample integrity....
5.
Calvino G, Peconi C, Strafella C, Trastulli G, Megalizzi D, Andreucci S, et al.
Genes (Basel)
. 2025 Jan;
15(12.
PMID: 39766917
Recent advancements in Next-Generation Sequencing (NGS) technologies have revolutionized genomic research, presenting unprecedented opportunities for personalized medicine and population genetics. However, issues such as data silos, privacy concerns, and regulatory...
6.
Pieracci G, Satriano F, DAgostino A, Rodini M, Caltagirone C, Formisano R, et al.
Appl Neuropsychol Adult
. 2025 Jan;
:1-13.
PMID: 39757953
Objective: Accelerated Long-term Forgetting (ALF) is a phenomenon characterized by abnormal memory forgetting over hours or days, despite normal initial acquisition. Because standardized memory assessments typically test memory retention over...
7.
Dopaminergic Treatment and Episodic Memory in Parkinson's Disease: A Meta-analysis of the Literature
Stanzione A, Melchiori F, Costa A, Leonardi C, Scalici F, Caltagirone C, et al.
Neuropsychol Rev
. 2024 Dec;
PMID: 39708069
To date, few studies have focused on the benefits of dopaminergic treatment on episodic memory functions in patients affected by Parkinson's disease (PD). We conducted a meta-analysis to determine the...
8.
Serra L, Bonarota S, Di Domenico C, Caruso G, Giulietti G, Rizzuti M, et al.
J Alzheimers Dis
. 2024 Nov;
102(1):181-194.
PMID: 39497309
Background: Reserves' mechanisms explain inconsistencies between accumulation of neuropathological damage and clinical manifestations. Leisure activities are believed to promote reserves. Objective: This study evaluates whether cognitive, social, and physical leisure...
9.
Argento O, Piacentini C, Bossa M, Caltagirone C, Santamato A, Saraceni V, et al.
NeuroSci
. 2024 Nov;
3(3):395-407.
PMID: 39483428
MS clinical features vary between patients. In approximately 60% of cases, cognitive deficits are associated with motor disabilities, with consequences on both walking and maintaining balance and cognitive efficiency. Multimodal...
10.
Megalizzi D, Trastulli G, Colantoni L, Proietti Piorgo E, Primiano G, Sancricca C, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39456731
Rare diseases are heterogeneous diseases characterized by various symptoms and signs. Due to the low prevalence of such conditions (less than 1 in 2000 people), medical expertise is limited, knowledge...